Literature DB >> 3046074

Thrombolytic therapy in cerebrovascular disease.

G J Del Zoppo1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3046074     DOI: 10.1161/01.str.19.9.1174

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  6 in total

1.  Combined direct percutaneous transluminal angioplasty and low-dose native tissue plasminogen activator therapy for acute embolic middle cerebral artery trunk occlusion.

Authors:  Takumi Yoneyama; Shinichi Nakano; Hirokazu Kawano; Tsutomu Iseda; Tokuro Ikeda; Tomokazu Goya; Shinichiro Wakisaka
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

2.  Reperfusion Therapy for Acute Middle Cerebral Artery Trunk Occlusion. Direct Percutaneous Transluminal Angioplasty Versus Intra-arterial Thrombolysis.

Authors:  S Nakano; S Wakisaka; T Yoneyama; H Kawano
Journal:  Interv Neuroradiol       Date:  2008-06-09       Impact factor: 1.610

Review 3.  Limiting neurological damage after stroke: a review of pharmacological treatment options.

Authors:  S J Read; T Hirano; S M Davis; G A Donnan
Journal:  Drugs Aging       Date:  1999-01       Impact factor: 3.923

Review 4.  What have drugs to offer the patient with acute stroke?

Authors:  D G Grosset
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

5.  Time- and pressure-dependent changes in blood-brain barrier permeability after temporary middle cerebral artery occlusion in rats.

Authors:  D J Cole; J S Matsumura; J C Drummond; R L Schultz; M H Wong
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Local intraarterial fibrinolysis in acute vertebrobasilar occlusion. Technical developments and recent results.

Authors:  H Zeumer; H J Freitag; U Grzyska; H P Neunzig
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.